Scott Crowe

Prof Scott Crowe is a leading academic and clinical researcher in radiation oncology medical physics, affiliated with the Royal Brisbane and Women’s Hospital and the Hudson Institute of Medical Research (HBI) Cancer Care Services. His work bridges clinical practice and advanced research in radiotherapy technologies.

• Clinical Role: Clinical Lead for Cancer Care Services at HBI, overseeing radiation oncology medical physics.
• Education: Post-doctoral fellowship at Queensland University of Technology (QUT).

Research Interests focus on:

• 3D Printing: Developing patient-specific phantoms and devices for radiotherapy applications (e.g., lung, vaginal, and oral molds).
• Dosimetry: Advancing measurement techniques (ionization chambers, Monte Carlo simulations) and addressing challenges like small field dose corrections, skin dose enhancement, and secondary cancer risk assessment.
• Adaptive Radiotherapy: Real-time motion adaptation systems, including Radixact Synchrony and TomoTherapy, to improve treatment accuracy.
• Quality Assurance: Statistical process control for beam energy variations, gamma evaluation methods, and machine performance checks.

Publication Trends highlight his expertise in integrating 3D printing with dosimetry, optimizing adaptive radiotherapy workflows, and improving quality assurance protocols. His work spans Monte Carlo simulations, proton therapy, and image-guided radiotherapy.

• Supervision: Mentors higher degree research students in radiation oncology physics.
• Conferences: Regular presenter at international scientific meetings.

Labs & Collaborations: Manages the radiation oncology medical physics research portfolio at Royal Brisbane and Women’s Hospital, collaborating with Hudson Institute on clinical translation projects.